Martin Shkreli - Net Worth and Insider Trading

Martin Shkreli Net Worth

The estimated net worth of Martin Shkreli is at least $33 Million dollars as of 2024-11-13. Martin Shkreli is the Fmr Officer Dir 10% Sharehldr of Travere Therapeutics Inc and owns about 1,765,168 shares of Travere Therapeutics Inc (TVTX) stock worth over $33 Million. Details can be seen in Martin Shkreli's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Martin Shkreli has not made any transactions after 2014-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Martin Shkreli

To

Martin Shkreli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Martin Shkreli owns 2 companies in total, including Humanigen Inc (HGENQ) , and Travere Therapeutics Inc (TVTX) .

Click here to see the complete history of Martin Shkreli’s form 4 insider trades.

Insider Ownership Summary of Martin Shkreli

Ticker Comapny Transaction Date Type of Owner
HGENQ Humanigen Inc 2016-08-25 10 percent owner
TVTX Travere Therapeutics Inc 2014-11-21 director & 10 percent owner & Chief Executive Officer

Martin Shkreli Latest Holdings Summary

Martin Shkreli currently owns a total of 1 stock. Martin Shkreli owns 1,765,168 shares of Travere Therapeutics Inc (TVTX) as of November 21, 2014, with a value of $33 Million.

Latest Holdings of Martin Shkreli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TVTX Travere Therapeutics Inc 2014-11-21 1,765,168 18.75 33,096,900

Holding Weightings of Martin Shkreli


Martin Shkreli Form 4 Trading Tracker

According to the SEC Form 4 filings, Martin Shkreli has made a total of 0 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years. The most-recent trade in Travere Therapeutics Inc is the sale of 1,172,000 shares on November 21, 2014, which brought Martin Shkreli around $10 Million.

Insider Trading History of Martin Shkreli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Martin Shkreli Trading Performance

GuruFocus tracks the stock performance after each of Martin Shkreli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin Shkreli is -19.45%. GuruFocus also compares Martin Shkreli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin Shkreli within 3 months outperforms 5 times out of 21 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Martin Shkreli's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Martin Shkreli

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
13 out of 21 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.62 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6 LIMIT LIMIT LIMIT LIMIT LIMIT

Martin Shkreli Ownership Network

Ownership Network List of Martin Shkreli

No Data

Ownership Network Relation of Martin Shkreli

Insider Network Chart

Martin Shkreli Owned Company Details

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Martin Shkreli is the 10 percent owner of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

Over the past 18 months, Martin Shkreli made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Humanigen Inc Insider Transactions

No Available Data

Martin Shkreli Mailing Address

Above is the net worth, insider trading, and ownership report for Martin Shkreli. You might contact Martin Shkreli via mailing address: 330 Madison Avenue, 6th Floor, New York Ny 10017.